158 related articles for article (PubMed ID: 34415199)
1. Minimizing table time in patients with claustrophobia using focused ferumoxytol-enhanced MR angiography (
Shahrouki P; Nguyen KL; Moriarty JM; Plotnik AN; Yoshida T; Finn JP
Br J Radiol; 2021 Sep; 94(1125):20210430. PubMed ID: 34415199
[TBL] [Abstract][Full Text] [Related]
2. Ferumoxytol-enhanced magnetic resonance angiography for the assessment of potential kidney transplant recipients.
Stoumpos S; Hennessy M; Vesey AT; Radjenovic A; Kasthuri R; Kingsmore DB; Mark PB; Roditi G
Eur Radiol; 2018 Jan; 28(1):115-123. PubMed ID: 28677065
[TBL] [Abstract][Full Text] [Related]
3. Ferumoxytol magnetic resonance angiography: a dose-finding study in patients with chronic kidney disease.
Stoumpos S; Hennessy M; Vesey AT; Radjenovic A; Kasthuri R; Kingsmore DB; Mark PB; Roditi G
Eur Radiol; 2019 Jul; 29(7):3543-3552. PubMed ID: 30919067
[TBL] [Abstract][Full Text] [Related]
4. USPIO-enhanced MR angiography of arteriovenous fistulas in patients with renal failure.
Sigovan M; Gasper W; Alley HF; Owens CD; Saloner D
Radiology; 2012 Nov; 265(2):584-90. PubMed ID: 22875796
[TBL] [Abstract][Full Text] [Related]
5. Continuously moving table aorto-iliofemoral run-off contrast-enhanced magnetic resonance angiography: image quality analysis in comparison to the multistep acquisition.
Asbach P; Meade MD; Sattenberg RJ; Klessen C; Huppertz A; Heidenreich JO
Acta Radiol; 2014 Apr; 55(3):266-72. PubMed ID: 24078458
[TBL] [Abstract][Full Text] [Related]
6. High-resolution three‑dimensional contrast‑enhanced magnetic resonance venography in children: comparison of gadofosveset trisodium with ferumoxytol.
Shahrouki P; Khan SN; Yoshida T; Iskander PJ; Ghahremani S; Finn JP
Pediatr Radiol; 2022 Mar; 52(3):501-512. PubMed ID: 34936018
[TBL] [Abstract][Full Text] [Related]
7. Crossover comparison of ferumoxytol and gadobenate dimeglumine for abdominal MR-angiography at 3.0 tesla: Effects of contrast bolus length and flip angle.
Schubert T; Motosugi U; Kinner S; Colgan TJ; Sharma SD; Hetzel S; Wells S; Campo CA; Reeder SB
J Magn Reson Imaging; 2017 Jun; 45(6):1617-1626. PubMed ID: 27862577
[TBL] [Abstract][Full Text] [Related]
8. Ferumoxytol as an off-label contrast agent in body 3T MR angiography: a pilot study in children.
Ruangwattanapaisarn N; Hsiao A; Vasanawala SS
Pediatr Radiol; 2015 Jun; 45(6):831-9. PubMed ID: 25427433
[TBL] [Abstract][Full Text] [Related]
9. The potential of ferumoxytol nanoparticle magnetic resonance imaging, perfusion, and angiography in central nervous system malignancy: a pilot study.
Neuwelt EA; Várallyay CG; Manninger S; Solymosi D; Haluska M; Hunt MA; Nesbit G; Stevens A; Jerosch-Herold M; Jacobs PM; Hoffman JM
Neurosurgery; 2007 Apr; 60(4):601-11; discussion 611-2. PubMed ID: 17415196
[TBL] [Abstract][Full Text] [Related]
10. Ferumoxytol-enhanced MR Angiography for Vascular Access Mapping before Transcatheter Aortic Valve Replacement in Patients with Renal Impairment: A Step Toward Patient-specific Care.
Nguyen KL; Moriarty JM; Plotnik AN; Aksoy O; Yoshida T; Shemin RJ; Suh WM; Finn JP
Radiology; 2018 Jan; 286(1):326-337. PubMed ID: 29040038
[TBL] [Abstract][Full Text] [Related]
11. Contrast-enhanced MR angiography of the chest and abdomen with use of controlled apnea in children.
Saleh RS; Patel S; Lee MH; Boechat MI; Ratib O; Saraiva CR; Finn JP
Radiology; 2007 Jun; 243(3):837-46. PubMed ID: 17517937
[TBL] [Abstract][Full Text] [Related]
12. Subtractionless compressed-sensing-accelerated whole-body MR angiography using two-point Dixon fat suppression with single-pass half-reduced contrast dose: feasibility study and initial experience.
Fu Q; Lei ZQ; Li JY; Wu JW; Liu XM; Fan WL; Sun P; Wang JZ; Liu DX; Yang F; Zheng CS; Kong XC
J Cardiovasc Magn Reson; 2023 Jul; 25(1):41. PubMed ID: 37475047
[TBL] [Abstract][Full Text] [Related]
13. MR Angiography of Renal Transplant Vasculature with Ferumoxytol:: Comparison of High-Resolution Steady-State and First-Pass Acquisitions.
Corwin MT; Fananapazir G; Chaudhari AJ
Acad Radiol; 2016 Mar; 23(3):368-73. PubMed ID: 26707344
[TBL] [Abstract][Full Text] [Related]
14. High resolution, 3-dimensional Ferumoxytol-enhanced cardiovascular magnetic resonance venography in central venous occlusion.
Shahrouki P; Moriarty JM; Khan SN; Bista B; Kee ST; DeRubertis BG; Yoshida T; Nguyen KL; Finn JP
J Cardiovasc Magn Reson; 2019 Mar; 21(1):17. PubMed ID: 30853026
[TBL] [Abstract][Full Text] [Related]
15. Use of a 1.0 Tesla open scanner for evaluation of pediatric and congenital heart disease: a retrospective cohort study.
Lu JC; Nielsen JC; Morowitz L; Musani M; Ghadimi Mahani M; Agarwal PP; Ibrahim el-SH; Dorfman AL
J Cardiovasc Magn Reson; 2015 May; 17(1):39. PubMed ID: 26004027
[TBL] [Abstract][Full Text] [Related]
16. Hepatic lesions: improved image quality and detection with the periodically rotated overlapping parallel lines with enhanced reconstruction technique--evaluation of SPIO-enhanced T2-weighted MR images.
Hirokawa Y; Isoda H; Maetani YS; Arizono S; Shimada K; Okada T; Shibata T; Togashi K
Radiology; 2009 May; 251(2):388-97. PubMed ID: 19401572
[TBL] [Abstract][Full Text] [Related]
17. Brand ferumoxytol vs. generic ferumoxytol comparison across two dosing regimens: a cardiac MRI image quality study.
Dasi A; Kring DN; Selvaraj B; Morgan P; Gerity C; Morgan EE; Krishnamurthy R; Krishnamurthy R
Pediatr Radiol; 2023 Dec; 53(13):2622-2632. PubMed ID: 37837456
[TBL] [Abstract][Full Text] [Related]
18. Image quality and diagnostic accuracy of unenhanced SSFP MR angiography compared with conventional contrast-enhanced MR angiography for the assessment of thoracic aortic diseases.
Krishnam MS; Tomasian A; Malik S; Desphande V; Laub G; Ruehm SG
Eur Radiol; 2010 Jun; 20(6):1311-20. PubMed ID: 20013276
[TBL] [Abstract][Full Text] [Related]
19. Three-dimensional cerebral contrast-enhanced magnetic resonance venography at 3.0 Tesla: initial results using highly accelerated parallel acquisition.
Nael K; Fenchel M; Salamon N; Duckwiler GR; Laub G; Finn JP; Villablanca JP
Invest Radiol; 2006 Oct; 41(10):763-8. PubMed ID: 16971800
[TBL] [Abstract][Full Text] [Related]
20. High-resolution 3D volumetric contrast-enhanced MR angiography with a blood pool agent (ferumoxytol) for diagnostic evaluation of pediatric brain arteriovenous malformations.
Iv M; Choudhri O; Dodd RL; Vasanawala SS; Alley MT; Moseley M; Holdsworth SJ; Grant G; Cheshier S; Yeom KW
J Neurosurg Pediatr; 2018 Sep; 22(3):251-260. PubMed ID: 29882734
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
